MedPath

ESP in Breast Surgery Due to Cancer

Phase 4
Completed
Conditions
Pain, Acute
Breast Cancer
Anesthesia, Local
Interventions
Procedure: General anesthesia
Procedure: Erector spinae plane block
Procedure: Sham block
Procedure: Patient-controlled analgesia
Registration Number
NCT04726878
Lead Sponsor
Medical University of Lublin
Brief Summary

Patients scheduled for breast surgery due to cancer. Each patient will be treated with intravenous (i.v.) oxycodone - patient-controlled analgesia (PCA). Patients will be allocated to one of three groups: erector spinae plane (ESP) block, sham block, controlled group.

Detailed Description

Only patients who are qualified for an elective procedure of mitral breast surgery may participate in the study. Each patient will be anesthetized generally. The same drugs will be used in each stage of anesthesia. The induction: propofol, fentanyl, rocuronium. The airway will be secured with a laryngeal mask airway (LMA). When there is a risk of aspiration, the patient will be intubated. Then, rocuronium or suxamethonium will be used. The anesthesia maintenance: sevoflurane, fentanyl. The emergence: oxygen, sugammadex or neostigmine a required.

After the induction of general anesthesia, an opaque envelope with the selected group will be opened. In the controlled group, the procedure will be continued in the patient's supine position. Women from the ESP and Sham groups will be placed in the lateral position. The operated side will be above. Then, the ultrasound-guided ESP block with saline or ropivacaine will be performed.

At the end of the surgery, an anesthesiologist will administer oxycodone intravenously (0.1 mg/KG).

After emergence from anesthesia, the patient will be transferred to the postoperative care unit. Vital signs will be monitored. The patient-controlled analgesia pump with oxycodone will be used.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
75
Inclusion Criteria
  • Elective surgery of breast due to cancer
  • obtained consent
Exclusion Criteria
  • the lack of consent
  • the surgery of two breasts
  • reoperation of the same breast
  • previous participation in the study
  • coagulopathy
  • allergy to morphine and local anesthetics
  • depression, antidepressant drugs treatment
  • epilepsy
  • usage of painkiller before surgery
  • addiction to alcohol or recreational drugs

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlledparacetamolStandard care without regional block. General anesthesia. After the end of the surgery, the patient-controlled analgesia with oxycodone.
ControlledPatient-controlled analgesiaStandard care without regional block. General anesthesia. After the end of the surgery, the patient-controlled analgesia with oxycodone.
Sham blockPatient-controlled analgesiaAfter the induction of general anesthesia, before the beginning of the surgery, the erector spinae plane block with 0.9% saline will be performed. Then, the patient will be treated as in the controlled group.
ESP blockPatient-controlled analgesiaAfter the induction of general anesthesia, before the beginning of the surgery, the erector spinae plane block with 0.375% ropivacaine will be performed. Then, the patient will be treated as in the controlled group.
ControlledGeneral anesthesiaStandard care without regional block. General anesthesia. After the end of the surgery, the patient-controlled analgesia with oxycodone.
Sham blockGeneral anesthesiaAfter the induction of general anesthesia, before the beginning of the surgery, the erector spinae plane block with 0.9% saline will be performed. Then, the patient will be treated as in the controlled group.
ESP blockErector spinae plane blockAfter the induction of general anesthesia, before the beginning of the surgery, the erector spinae plane block with 0.375% ropivacaine will be performed. Then, the patient will be treated as in the controlled group.
Sham blockSham blockAfter the induction of general anesthesia, before the beginning of the surgery, the erector spinae plane block with 0.9% saline will be performed. Then, the patient will be treated as in the controlled group.
ESP blockGeneral anesthesiaAfter the induction of general anesthesia, before the beginning of the surgery, the erector spinae plane block with 0.375% ropivacaine will be performed. Then, the patient will be treated as in the controlled group.
ESP blockparacetamolAfter the induction of general anesthesia, before the beginning of the surgery, the erector spinae plane block with 0.375% ropivacaine will be performed. Then, the patient will be treated as in the controlled group.
Sham blockparacetamolAfter the induction of general anesthesia, before the beginning of the surgery, the erector spinae plane block with 0.9% saline will be performed. Then, the patient will be treated as in the controlled group.
ESP blockOxycodoneAfter the induction of general anesthesia, before the beginning of the surgery, the erector spinae plane block with 0.375% ropivacaine will be performed. Then, the patient will be treated as in the controlled group.
ControlledOxycodoneStandard care without regional block. General anesthesia. After the end of the surgery, the patient-controlled analgesia with oxycodone.
Sham blockOxycodoneAfter the induction of general anesthesia, before the beginning of the surgery, the erector spinae plane block with 0.9% saline will be performed. Then, the patient will be treated as in the controlled group.
Primary Outcome Measures
NameTimeMethod
Quality of recovery 40Before the hospital discharge

Quality of recovery (QoR) score containing 40 items. This questionnaire measures the early postoperative health status of patients. Minimum is 40, maximum is 200. More points is better.

Secondary Outcome Measures
NameTimeMethod
Patient-controlled analgesia (PCA)24 hours from the connection of the PCA pump in the post-anesthesia care unit.

All good and bad demands with PCA pump.

Visual analog scaleup to 24 hours after the surgery

Acute pain measured with VAS (visual analog scale). From 0 (no pain) to 100. More on the scale is worse.

Total oxycodone consumptionup to 24 hours after the surgery

Consumption of oxycodone with PCA pump, loading, and additional doses.

Trial Locations

Locations (1)

II Department of Anesthesia and Intensive Care, Medical University of Lublin

🇵🇱

Lublin, Poland

II Department of Anesthesia and Intensive Care, Medical University of Lublin
🇵🇱Lublin, Poland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.